Introduction
Materials and Methods
Plant material and sample preparation
Test Microorganisms
Antibiotics
Minimum Inhibitory Concentration
Checkerboard dilution test
Colorimetric assay using MTT test
Results
Discussion
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has been a problem since the 1960s as its infection is associated with higher mortality and increase cost in the hospitals (Klevens et al., 2007; Joung et al., 2012). It becomes more and more evident that bacteria, when faced with a new developed drug, respond with clever mechanisms of resistance (Tenover, 2006). Today, with this emergence of antibiotic resistant pathogens like MRSA, a new approach to natural products must be taken. These natural products are increasingly in demand due to their non-side effect benefit (Ghosh et al., 2008). Therefore, our ongoing efforts to find bioactive natural products have led us to study the antibacterial activity of Lysimachia clethroides Duby. The primary purpose of this study was to investigate the in vitro effect against MRSA. Lysimachia clethroides Duby, one of the species of genus Lysimachia, is a traditional folk Chinese medicine, distributed widely in many provinces of China. This plant has been used widely for treatment of throat ache, edema, and menoschesis (Bae, 1998).
It has also been shown to have antimicrobial activity on food-borne microorganisms (Han et al., 2001). Chemical study showed Astragalin, Isoquercitrin, Kaempferol-3-rutinoside, kaempferol-3-0-(2,6-di-o-rhamnopyranosylglucopyranoside), Kaempferol-3-0-(rhamnopyranosylglucopyranoside) (Yasukawa et al., 1986). Flavonoids and saponins (Zou et al., 2004; Ren et al., 2001) were present in this plant and the flavonoids were proved to be the main biological constituents, with the activities of anti-tumor, anti-bacterial and anti-platelet aggregation (Xu et al., 2003). However, little is known about its antimicrobial effects on MRSA. Thus, we present the current study demonstrating the antimicrobial activity of Lysimachia clethroides Duby against MRSA and methicillin-sensitive (MSSA) strains, as well as its synergistic effect.
Materials and Methods
Plant material and sample preparation
Lysimachia clethroides Duby roots were collected from Sunchon, southern Republic of Korea, in June, 2017. A voucher specimen was deposited in the Laboratory of Oriental Pharmacology (N.1369). Lysimachia clethroides Duby root was air-dried, and boiled in ethanol (2L for 3h). The ethanol extract of Lysimachia clethroides Duby root (5.67% w/w) was partitioned with organic solvents of different polarities to yield n-hexane, EtOAc, n-BuOH and water fractions, in sequence. The samples were stored at 4℃.
Test Microorganisms
Fourteen Clinical isolates (MRSA) were obtained from fourteen different patients at Wonkwang University Hospital (Iksan, South Korea). The Other 2 strains were S. aureus ATCC 33591 (Methicillin-resistant strain) and S. aureus ATCC 25923 (Methicillin-susceptible strain). Before use, all of the bacteria were stored in 30% glycerol and frozen at -70℃. The bacteria were cultured in Mueller-Hinton Broth (MHB) and Mueller-Hinton Agar (MHA) (Difco Laboratories, Baltimore, MD, USA). The bacteria were suspended in Mueller-Hinton Broth and then incubated at 37℃ for 24 hr.
Antibiotics
Ampicillin (AM) and Oxacillin (OX) (Sigma Chemical Co. St. Louis, M0, USA) were used.
Minimum Inhibitory Concentration
The Minimum Inhibitory Concentration (MIC) was determined using the broth microdilution method according to the clinical and Laboratory standards Institute guideline (CLSI., 2000). Briefly, a preparation of the microorganisms inoculated were done on 24 hr Broth cultures, and the suspensions were adjusted to a 0.5 McFarland standard turbidity (approximately 1.5×108 CFU/㎖). Final inoculums were adjusted to the 1.5×106 CFU/㎖. These serially diluted cultures were then incubated at 37℃ for 18 hr. MIC was defined at the lowest concentration of AM, OX, Lysimachia clethroides Duby extracts, Fractions (n-hexane, EtOAc, n-BuOH, H2O). At the end of the incubation period, the well plates were visually examined for turbidity. Cloudiness indicates that bacterial growth has not been inhibited by the concentration of antimicrobial agents contained in the medium. A colorimetric assay for rapid detection of the presence of bacteria was also performed (see below, Colorimetric assay using 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide [MTT] test).
Checkerboard dilution test
The synergistic combinations were investigated in the preliminary checkerboard method performed using the MRSA, MSSA and the five isolate strains came from fourteen patients via MIC determination, according to the CLSI guidelines (Mazumdar et al., 2005). The MIC was defined as the lowest concentration of drug alone or in combination that inhibited the visible growth. The in vitro interaction was quantified by determining the fractional inhibitory concentration (FIC). The FIC index was calculated as follows: FIC = (MIC of drug A in combination/MIC of drug A alone) + (MIC of drug B in combination/MIC of drug B alone). FIC indices (FICI) were interpreted as follows: <0.5, synergy; 0.5-0.75, partial synergy; 0.76-1.0, additive effect; >1.0-4.0, indifference; and >4.0, antagonism. All experiments were independently repeated three times.
Colorimetric assay using MTT test
A colorimetric assay based on MTT for rapid detection of the presence of bacteria was performed as previously described (Luis et al., 2014; Joung et al., 2015; Shi et al., 2008). Briefly, a stock solution of 5 ㎎/㎖ MTT (Sigma) was prepared in phosphate-buffered saline and kept at -70℃. A final concentration of 1 ㎎/㎖ of MTT was used in the assay. After 24hrs of incubation a 37℃, 20 ㎕ of the yellow MTT was added to the 96-well microtiter plate and incubated for an additional 20 min. The presence of a blue color indicates the presence of bacteria.
Results
Ethanol extract had a MIC of 250 ㎍/㎖ against S. aureus ATCC 33591 under dark, and had a MIC of 250 ㎍/㎖ against S. aureus ATCC 25923 in the same condition. Antimicrobial activity of n-hexane fraction was remarkable, and had a MIC of from 15.62 ㎍/㎖ to 62.5 ㎍/㎖ against S. aureus strains (Table 1 and Table 2). n-hexane fraction of Lysimachia clethroides Duby root (HFL) lowered the MICs against the MRSA strain and MSSA but FICI values for HFL+AM and HFL+OX were 0.12-1 and 0.25-0.75, showing the increase of synergistic effect (Table 3 and 4).
Table 1. The S. aureus strains used in the experiments
yAM, ampicillin; OX, oxacillin.
xDPS-1 indicates Staphylococcus aureus strains from the Department of Plastic Surgery, Wonkwang University Hospital.
Table 2. Antimicrobial activity of Lysimachia clethroides Duby root ethanol extract, n-hexane, EtOAc, n-BuOH and water fractions against S. aureus strains under dark
Table 3. Result of the combined effect of n-hexane fraction of Lysimachia clethroides Duby root and AM against S. aureus
bHFL; n-hexane fraction of Lysimachia clethroides Duby root.
aDPS; indicates Staphylococcus aureus strains from the Department of Plastic Surgery, Wonkwang University Hospital.
Table 4. Result of the combined effect of n-hexane fraction of Lysimachia clethroides Duby root and OX against S. aureus
bHFL; n-hexan fraction of Lysimachia clethroides Duby root
aDPS; indicates Staphylococcus aureus strains from the department of plastic surgery Wonkwang University Hospital.
Discussion
The most effective method is to develop antibiotics from the natural products without having any toxic or side effects. Therefore, there is a need to develop alternative antimicrobial drugs for the treatment of infections diseases. Combination therapy is the most commonly recommended empirical treatment for bacterial infections in intensive care units, where monotherapy may not be effective against all potential pathogens, and for preventing the emergence of resistant mutants (Drago et al., 2007; Joung et al., 2016). When combined together, these antibiotic effects were dramatically increased. Different drug combinations are reported to treat infections caused by pathogens (Miranda-Novales et al., 2006; Drago et al., 2007; Liu et al., 2000). The (Methicillin-resistant) of 15 MRSA strains and S. aureus ATCC 25923 (Methicillin-susceptible strain) to the tested antibiotics. Antimicrobial activity of n-hexane fraction was remarkable, and had a MICs ranging from 31.25 ㎍/㎖ to 62.5 ㎍/㎖ and checkerboard dilution test was performed to determine the action of HFL alone as well as its synergistic action with AM, or OX against the 16 strains. When tested against ATCC 33591, our data indicated that HFL alone only had moderate inhibitory effect on the growth of MRSA. However, in the presence of a nongrowth inhibitory dose of HFL (31.25 ㎍/㎖) or AM (1000 ㎍/㎖), HFL together with AM was highly effective with a FICI of 0.5. Similar effects were also observed in MSSA strain. These results showed that HFL in combination with these antibiotics could effectively inhibit MRSA growth. It may be partly due to the fact that they had abundant flavonoids which contributed to their antimicrobial activity and should be further studied. In conclusion, we found that Lysimachia clethroides Duby root extracts and n-hexane fraction have an antibacterial effect on MRSA and MSSA, and showing the increase of synergistic effect.